INS and Hyperglycemia: Combining the HFD with a higher dose of STZ (120 mg kg−1) resulted in the development of frank hyperglycaemia and hypoinsulinaemia (but not loss of insulin) at the same time as the retention of an obese and hyperlipidaemic phenotype.